D. E. Shaw & Co »

Bioxcel Therapeutics shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Bioxcel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bioxcel Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioxcel Therapeutics by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $125k 42k 2.95
2020-06-30 $1.0M 19k 53.03

More positions owned by D. E. Shaw & Co

Microsoft Corporation Put Option (MSFT)
Apple Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A Call Option (META)
Booking Holdings (BKNG)
Netflix Put Option (NFLX)
Advanced Micro Devices Put Option (AMD)
Chipotle Mexican Grill (CMG)
Tesla Motors (TSLA)
Uber Technologies Put Option (UBER)
Exxon Mobil Corporation Put Option (XOM)
Citigroup Com New (C)
Alphabet Cap Stk Cl A (GOOGL)
Royal Caribbean Cruises Put Option (RCL)

View all positions for D. E. Shaw & Co

Top funds holding Bioxcel Therapeutics

Vanguard Group
Beacon Pointe Advisors
Charles Schwab Investment Management
Citadel Advisors
Bank of New York Mellon
Arete Wealth Advisors
Bank of America Corporation
Bank Of Montreal
Millennium Management
Wells Fargo & Company
Virtu Financial
Squarepoint Ops
Tocqueville Asset Management
UBS Group
D. E. Shaw & Co

View all funds holding Bioxcel Therapeutics